(15056323), A. A. O., (15056326), E. A., (15056329), M. B., (15056332), C. M., (15056335), A. L., (15056338), K. T., . . . (15026901), J. N. M. (2025). Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma.
Чикаго стиль цитування (17-те видання)(15056323), Abdullah A. Osman, et al. Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma. 2025.
Стиль цитування MLA (9-ме видання)(15056323), Abdullah A. Osman, et al. Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma. 2025.